Buprenorphine: Completed Phase III enrollment

Titan completed enrollment of 250 patients in a placebo- and active-controlled, U.S. Phase III trial to compare Probuphine to sublingual Suboxone buprenorphine/naloxone from Reckitt Benckiser Group...